BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26752083)

  • 1. Forced degradation, LC-UV, MS(n) and LC-MS-TOF studies on azilsartan: Identification of a known and three new degradation impurities.
    Kaushik D; Kaur J; Paul Kaur V; Saini B; Bansal Y; Bansal G
    J Pharm Biomed Anal; 2016 Feb; 120():202-11. PubMed ID: 26752083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid chromatography/tandem mass spectrometry study of forced degradation of azilsartan medoxomil potassium.
    Swain D; Patel PN; Palaniappan I; Sahu G; Samanthula G
    Rapid Commun Mass Spectrom; 2015 Aug; 29(15):1437-47. PubMed ID: 26147484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of four new degradation products of epirubicin through forced degradation, LC-UV, MSn and LC-MS-TOF studies.
    Kaushik D; Saini B; Bansal G
    J Chromatogr Sci; 2015; 53(10):1737-48. PubMed ID: 26162378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of degradation products of idarubicin through LC-UV, MS(n) and LC-MS-TOF studies.
    Kaushik D; Bansal G
    J Pharm Biomed Anal; 2013 Nov; 85():123-31. PubMed ID: 23933565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LC-UV-PDA and LC-MS studies to characterize degradation products of glimepiride.
    Bansal G; Singh M; Jindal KC; Singh S
    J Pharm Biomed Anal; 2008 Nov; 48(3):788-95. PubMed ID: 18804934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Rapid Novel HPLC Method for Estimation of Eight Related Compounds in Azilsartan Kamedoxomil and Identification of Degradation Compounds by Using LC-MS.
    Sreenivasulu J; Venkata Ramana P; Sampath Kumar Reddy G; Nagaraju ChV; Thirumalai Rajan S; Eswaraiah S
    J Chromatogr Sci; 2015 Oct; 53(9):1463-74. PubMed ID: 25925084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MS2/TOF and LC-MS/TOF studies on toremifene to characterize its forced degradation products.
    Bansal G; Maddhesia PK; Bansal Y
    Analyst; 2011 Dec; 136(24):5218-28. PubMed ID: 22013582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability-indicating RP-LC method for determination of azilsartan medoxomil and chlorthalidone in pharmaceutical dosage forms: application to degradation kinetics.
    Ebeid WM; Elkady EF; El-Zaher AA; El-Bagary RI; Patonay G
    Anal Bioanal Chem; 2014 Oct; 406(26):6701-12. PubMed ID: 25190009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS/MS characterization of forced degradation products of zofenopril.
    Ramesh T; Nageswara Rao P; Nageswara Rao R
    J Pharm Biomed Anal; 2014 Jan; 88():609-16. PubMed ID: 24211724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid chromatography tandem mass spectrometric studies of indinavir sulphate and its forced degradation products.
    Rao RN; Vali RM; Raju SS
    J Pharm Biomed Anal; 2013 Feb; 74():101-10. PubMed ID: 23245240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MS(n) , LC-MS-TOF and LC-PDA studies for identification of new degradation impurities of bupropion.
    Bansal R; Saini B; Bansal Y; Bansal G
    Biomed Chromatogr; 2013 Nov; 27(11):1387-97. PubMed ID: 23798322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-MS/MS structural characterization of stress degradation products including the development of a stability indicating assay of Darunavir: An anti-HIV drug.
    Rao RN; Ramachandra B; Sravan B; Khalid S
    J Pharm Biomed Anal; 2014 Feb; 89():28-33. PubMed ID: 24252722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of stress degradation products of dronedarone hydrochloride employing LC-UV/PDA, LC-MS/TOF and MS(n) studies.
    Chadha R; Bali A; Bansal G
    J Pharm Biomed Anal; 2016 Jan; 118():139-148. PubMed ID: 26547261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of degradation products of ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis.
    Patel PN; Borkar RM; Kalariya PD; Gangwal RP; Sangamwar AT; Samanthula G; Ragampeta S
    J Mass Spectrom; 2015 Feb; 50(2):344-53. PubMed ID: 25800016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of forced degradation behavior of enalapril maleate by LC and LC-MS and development of a validated stability-indicating assay method.
    Bhardwaj SP; Singh S
    J Pharm Biomed Anal; 2008 Jan; 46(1):113-20. PubMed ID: 17964751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction.
    Kalariya PD; Raju B; Borkar RM; Namdev D; Gananadhamu S; Nandekar PP; Sangamwar AT; Srinivas R
    J Mass Spectrom; 2014 May; 49(5):380-91. PubMed ID: 24809899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of four new photodegradation products of hydroxychloroquine through LC-PDA, ESI-MSn and LC-MS-TOF studies.
    Saini B; Bansal G
    J Pharm Biomed Anal; 2013 Oct; 84():224-31. PubMed ID: 23850938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-MS/MS studies of ritonavir and its forced degradation products.
    Rao RN; Ramachandra B; Vali RM; Raju SS
    J Pharm Biomed Anal; 2010 Dec; 53(4):833-42. PubMed ID: 20619992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of stressed degradation products of metoprolol using LC/Q-TOF-ESI-MS/MS and MS(n) experiments.
    Borkar RM; Raju B; Srinivas R; Patel P; Shetty SK
    Biomed Chromatogr; 2012 Jun; 26(6):720-36. PubMed ID: 21989963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.